Clinical Trial Update: Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating probiotic supplementation to prevent chemotherapy-related diarrhea in cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Probiotic supplementation

Snippet

Sponsor: Stanford University | Conditions: Diarrhea, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: WITHDRAWN